1. Home
  2. IOVA vs GNL Comparison

IOVA vs GNL Comparison

Compare IOVA & GNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.05

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Global Net Lease Inc.

GNL

Global Net Lease Inc.

HOLD

Current Price

$9.63

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
GNL
Founded
2007
2011
Country
United States
United States
Employees
N/A
56
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
GNL
Price
$4.05
$9.63
Analyst Decision
Buy
Buy
Analyst Count
10
2
Target Price
$9.11
$9.50
AVG Volume (30 Days)
18.2M
1.8M
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
8.09%
EPS Growth
14.84
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$49.14
N/A
Revenue Next Year
$51.69
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$6.51
52 Week High
$5.63
$10.04

Technical Indicators

Market Signals
Indicator
IOVA
GNL
Relative Strength Index (RSI) 54.36 56.95
Support Level $1.99 $9.23
Resistance Level $4.34 $10.04
Average True Range (ATR) 0.47 0.23
MACD -0.05 -0.01
Stochastic Oscillator 24.18 75.76

Price Performance

Historical Comparison
IOVA
GNL

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About GNL Global Net Lease Inc.

Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.

Share on Social Networks: